Searched for
MORAIYA PLANT
Buy Cadila Healthcare, target Rs 315: Nirmal Bang SecuritiesCadila Healthcare is a largecap company, operating in pharmaceuticals and health care sector.- CLSA downgrades Cadila Healthcare to 'sell'US FDA recently inspected Cadila's Moraiya facility and issued a Form 483 with 14 observations.
- CLSA upgrades Cadila Healthcare to 'buy'Shares of Cadila ended down 1.74 per cent at Rs 369.95 on the BSE on Friday.
- Zydus Cadila shares rise 3.41% after USFDA clears Moraiya plantThe USFDA inspected Cadila’s Moraiya facility from August 31-September 7.
- Zydus Cadila gets USFDA nod to market anti-dementia tablets"Zydus Cadila has received final approval from the USFDA to market Memantine Hydrochloride tablets USP, 5mg and 10mg," Cadila Healthcare sa...
- Cadila receives audit closure reportThe Moraiya manufacturing plant had completed the USFDA audit from February 6th to 15th 2017 with Zero 483 observations, the company said.
- Will bring our latest drug Lialda by August: Nitin Kumar Parekh, Director - Finance, CadilaCadila will bring out its latest drug, Lialda, in July or August, revealed Nitin Kumar Parekh, Director - Finance, Cadila.
- Cadila Healthcare surges 7% on receiving USFDA approval for levofloxacin injectionThe stock climbed 7.18 per cent to hit a high of Rs 504.8 on BSE.
- Zydus Cadila gets USFDA nod for levofloxacin injectionThe Gujarat group has more than 115 approvals and has so far filed over 300 abbreviated new drug applications (ANDAs) since it commenced fi...
- RBL Bank among top trading ideas for next week: Yogesh Mehta, Motilal Oswal SecuritiesMehta says Cadila Healthcare has been re-rated after the drugmaker received USFDA clearance for its Moraiya plant. The target price has bee...
- Margin improvement will happen once new approvals come in: Pankaj Patel of Cadila HealthcareWe should expect significant approval coming in, in FY18 we expect 40 plus approvals may be happening now.
- CLSA raises target price of Cadila Healthcare; should you buy?The global brokerage house said, “Moraiya outcome a big surprise but approvals may take time.” CLSA believes benefits of Moraiya's clearanc...
- USFDA inspects Cadila Healthcare's Moraiya facility"USFDA inspected company's Moraiya facility from February 6, 2017 to February 15, 2017. At the end of the inspection no observation (483) i...
- Cadila Healthcare gets EIR for Ahmedabad plant from USFDA"The company's Oral Solid Dosage drug manufacturing plant located at SEZ, Ahmedabad has received an Establishment Inspection Report (EIR) f...
- Cadila gets EIR from USFDA for Changodar facilityLast month, Cadila Healthcare had received Establishment Inspection Report (EIR) from the US health regulator for its manufacturing facilit...
- Cadila Healthcare extends losses; company clarifiesThe stock fell 2.97 per cent to hit a low of Rs 313.60 on BSE. This was the third day of consecutive fall for the stock.
- Cadila gets US FDA warning for violating standards at Moraiya and Ahmedabad plantsThe company said its Moraiya and Ahmedabad facilities have been cited in the letter, and it is working on responding to the FDA concerns re...
- Twelve stocks in focus in Friday's tradeIndian markets are expected to trade lower. Here is a list of twelve stocks which are likely to remain in focus today.
- Cadila Healthcare PAT seen down 16% at Rs 192crNet sales are expected to have grown 4 per cent to Rs 1,466 crore in the first quarter from Rs 1,173 crore in the year-ago period. Earnings...
- USFDA revoke's warning to Cadila HealthcareThe US drug regulator has revoked its earlier warning letter to Ahmedabad-based Cadila Healthcare Ltd.
Load More
